Skip to content
The Nexus
HEALTHAug 4 · 17:04 UTCSTAT NEWSJason Mast and Allison DeAngelis

STAT+: Startup promising to scale custom CRISPR therapies abruptly scraps plans

Aurora Therapeutics, a startup focused on personalized gene-editing drugs, has scrapped its lead program and reduced staff, reportedly due to competition from Beam Therapeutics, which advanced similar therapies for the same disease.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Aurora TherapeuticsorganizationBeam TherapeuticsorganizationCRISPR therapiestopicpersonalized gene-editing drugstopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting

STAT+: Startup promising to scale custom CRISPR therapies abruptly scraps plans · The Nexus